Page 1 of Clinical Trials for Erosive Gastroesophageal Reflux Disease, 59 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease
Last Updated: May 4, 2012
Condition(s): GERD
2
Completed
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Last Updated: March 24, 2010
Condition(s): Gastroesophageal Reflux Disease (GERD)
3
Completed
Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Last Updated: March 17, 2010
Condition(s): Gastroesophageal Reflux Disease (GERD)
4
Completed
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Last Updated: March 10, 2010
Condition(s): Gastroesophageal Reflux Disease (GERD)
5
Completed
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Last Updated: March 10, 2010
Condition(s): Gastroesophageal Reflux Disease (GERD)
6
Completed
Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Last Updated: March 16, 2010
Condition(s): Gastroesophageal Reflux Disease (GERD)
7
Completed
Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)
Last Updated: May 4, 2012
Condition(s): Erosive Gastroesophageal Reflux Disease; Non-Erosive Reflux Disease
8
Completed
Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)
Last Updated: May 4, 2012
Condition(s): Gastroesophageal Reflux Disease
9
Completed
Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
Last Updated: May 4, 2012
Condition(s): Sleep Disorders; Non-Erosive Reflux Disease; Gastroesophageal Reflux Disease
10
Completed
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)
Last Updated: May 4, 2012
Condition(s): Gastroesophageal Reflux
11
Completed
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)
Last Updated: May 4, 2012
Condition(s): Gastroesophageal Reflux
12
Completed
Impact of GERD on Daily Life (NIS)
Last Updated: January 25, 2012
Condition(s): GERD
13
Completed
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients
Last Updated: April 12, 2012
Condition(s): GERD; Gastroesophageal Reflux Disease
14
Completed
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD).
Last Updated: May 21, 2012
Condition(s): Gastroesophageal Reflux
15
Completed
Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease
Last Updated: May 4, 2012
Condition(s): Gastroesophageal Reflux Disease
16
Completed
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)
Last Updated: February 13, 2012
Condition(s): Gastroesophageal Reflux
17
Recruiting
Comparison of Nexium VS. Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.
Last Updated: August 18, 2010
Condition(s): Gastroesophageal Reflux Disease (GERD); Heartburn; Indigestion
18
Completed
Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)
Last Updated: May 4, 2012
Condition(s): Gastroesophageal Reflux Disease
19
Completed
Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)
Last Updated: May 4, 2012
Condition(s): GERD
20
Completed
Esomeprazole for Treatment of GERD in Pediatric Patients
Last Updated: November 18, 2010
Condition(s): Gastroesophageal Reflux Disease (GERD); Erosive Esophagitis; Non-erosive Esophagitis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Erosive+Gastroesophageal+Reflux+Disease

Page 1 of Clinical Trials for Erosive Gastroesophageal Reflux Disease, 59 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About